Collaborating for the Advancement of Interdisciplinary Research in Benign Urology
Supports research that advances medical and scientific knowledge relating to urology, urogynecology, endourology, patients treated in these areas, associated caregivers, and the health care providers who work in these areas. Open to all qualified researchers.
Supported studies initiated, developed, designed, and managed by a qualified third-party investigator who assumes sole responsibility for the conduct and management of the research. [Annual Deadlines: 3/28, 6/27, 9/26, 12/19.]
Supports the early and conceptual stages of exploratory and developmental research projects that may involve considerable risk but may lead to a breakthrough in a particular area or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. [Posted 12/18/2024. Expires 01/08/2028.]
Provides a new pathway for ESIs who wish to propose research projects in a new direction for which preliminary data do not exist. Open to a broad range of scientific research relevant to the mission of the participating NIH Institutes and Centers (ICs), notably NIA, NICHD, ORWH. [Posted August 25, 2025. Expires August 26, 2028.]
Providers a new pathway for ESIs to propose research projects in a new direction for which preliminary data do not exist. Open to a broad range of scientific research relevant to the mission of the participating NIH Institutes and Centers, including NIDDK, NIA, NICHD, & NIAD. [Posted 8/25/2025. Expires 8/26/2028.]
The George M. O’Brien Kidney Resource Alliance (OKRA) is excited to announce the third offering of the OKRA Opportunity Pool Program. This program will support large pilot grants (up to a maximum of $50,000 total costs) addressing scientific and technological gaps in kidney research and promoting new collaborations.
Hundreds of millions of people, both nationally and globally, are directly impacted by non-cancerous genitourinary (GU) diseases and disorders. These conditions, including but not limited to UTIs, urolithiasis (kidney stones), urinary incontinence, over/underactive bladder, pelvic pain syndrome, and erectile dysfunction cost over $11.5 billion dollars to treat annually. To improve GU clinical treatment and patient …
A non-exhaustive list of publications authored by CAIRIBU Urobiome RIG participants from 2021 to 2023. Publication dates range from 2015 to August 2023.
In this review, we present a set of poorly understood, emerging, and suspected uropathogens. The goal is to stimulate research into the biology of these microbes with a focus on their life as commensals and their transition into pathogens.
Despite the high incidence of UTI diagnoses, the high cost of UTI treatment, and increasing concerns associated with antimicrobial resistance, the development of novel and more accurate UTI tests has not been considered a priority, in part due to the general perception that current UTI care is already sufficient. In this review, we discuss the importance of improving UTI diagnostic testing to improve treatment outcomes.
